Abbott Laboratories, founded in 1888 and headquartered in Abbott Park, Illinois, is a global healthcare company dedicated to advancing health through the development of innovative products and technologies. The company operates in several segments, including nutrition, diagnostics, medical devices, and pharmaceuticals, offering a wide range of products such as baby formula, blood glucose monitoring systems, and cardiac devices.
| Bond Name | Country | Maturity | Coupon(%) |
|---|
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Abbott began issuing corporate bonds in the early 1990s and has since become a noteworthy player in the fixed-income market. Significant bond issuances include the $1 billion 10-year note in 2020, which was aimed at financing acquisitions and general corporate purposes. Currently, Abbott's bond yields are competitive within the healthcare sector, reflecting its strong credit rating and consistent performance. Notable features of Abbott's bonds include callable options and attractive interest rates, making them appealing to income-focused investors. Recent news includes increased bond demand as investors seek stable returns amid market volatility.